239 related articles for article (PubMed ID: 29844130)
1. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
Anderson BW; Suh YS; Choi B; Lee HJ; Yab TC; Taylor WR; Dukek BA; Berger CK; Cao X; Foote PH; Devens ME; Boardman LA; Kisiel JB; Mahoney DW; Slettedahl SW; Allawi HT; Lidgard GP; Smyrk TC; Yang HK; Ahlquist DA
Clin Cancer Res; 2018 Nov; 24(22):5724-5734. PubMed ID: 29844130
[No Abstract] [Full Text] [Related]
2. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.
Qin Y; Wu CW; Taylor WR; Sawas T; Burger KN; Mahoney DW; Sun Z; Yab TC; Lidgard GP; Allawi HT; Buttar NS; Smyrk TC; Iyer PG; Katzka DA; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2019 Dec; 25(24):7396-7404. PubMed ID: 31527170
[TBL] [Abstract][Full Text] [Related]
3. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
[TBL] [Abstract][Full Text] [Related]
4. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
Kisiel JB; Dukek BA; V S R Kanipakam R; Ghoz HM; Yab TC; Berger CK; Taylor WR; Foote PH; Giama NH; Onyirioha K; Abdallah MA; Burger KN; Slettedahl SW; Mahoney DW; Smyrk TC; Lewis JT; Giakoumopoulos M; Allawi HT; Lidgard GP; Roberts LR; Ahlquist DA
Hepatology; 2019 Mar; 69(3):1180-1192. PubMed ID: 30168613
[TBL] [Abstract][Full Text] [Related]
6. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.
Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Yab TC; Simonson JA; Devens ME; Slettedahl SW; Mahoney DW; Berger CK; Foote PH; Smyrk TC; Wang KK; Wolfsen HC; Ahlquist DA
Am J Gastroenterol; 2018 Aug; 113(8):1156-1166. PubMed ID: 29891853
[TBL] [Abstract][Full Text] [Related]
7. High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9.
Majumder S; Taylor WR; Foote PH; Berger CK; Wu CW; Mahoney DW; Bamlet WR; Burger KN; Postier N; de la Fuente J; Doering KA; Lidgard GP; Allawi HT; Petersen GM; Chari ST; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 May; 27(9):2523-2532. PubMed ID: 33593879
[TBL] [Abstract][Full Text] [Related]
8. Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence.
Xie H; Mahoney DW; Foote PH; Burger KN; Doering KA; Taylor WR; Then SS; Cao X; McGlinch M; Berger CK; Wu TT; Hubbard JM; Allawi HT; Kaiser MW; Lidgard GP; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2021 Jan; 27(1):141-149. PubMed ID: 33028593
[TBL] [Abstract][Full Text] [Related]
9. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
[TBL] [Abstract][Full Text] [Related]
10. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study.
Qin Y; Taylor W; Bamlet WR; Ravindran A; Buglioni A; Cao X; Foote PH; Slettedahl SW; Mahoney DW; Albert PS; Kim S; Hu N; Taylor PR; Etemadi A; Sotoudeh M; Malekzadeh R; Abnet CC; Smyrk TC; Katzka D; Topazian MD; Dawsey SM; Ahlquist D; Kisiel JB; Iyer PG
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2642-2650. PubMed ID: 32948633
[TBL] [Abstract][Full Text] [Related]
11. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.
Majumder S; Raimondo M; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Devens ME; Mahoney DW; Smyrk TC; Pannala R; Chari ST; Vege SS; Topazian MD; Petersen BT; Levy MJ; Rajan E; Gleeson FC; Abu Dayyeh B; Nguyen CC; Faigel DO; Woodward TA; Wallace MB; Petersen G; Allawi HT; Lidgard GP; Kisiel JB; Ahlquist DA
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):676-683.e3. PubMed ID: 31323382
[TBL] [Abstract][Full Text] [Related]
12. Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia.
Ballester V; Taylor WR; Slettedahl SW; Mahoney DW; Yab TC; Sinicrope FA; Boland CR; Lidgard GP; Cruz-Correa MR; Smyrk TC; Boardman LA; Ahlquist DA; Kisiel JB
Epigenomics; 2020 Dec; 12(24):2173-2187. PubMed ID: 33350853
[No Abstract] [Full Text] [Related]
13. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Markers for Breast Cancer Detection in the Developing World.
Downs BM; Mercado-Rodriguez C; Cimino-Mathews A; Chen C; Yuan JP; Van Den Berg E; Cope LM; Schmitt F; Tse GM; Ali SZ; Meir-Levi D; Sood R; Li J; Richardson AL; Mosunjac MB; Rizzo M; Tulac S; Kocmond KJ; de Guzman T; Lai EW; Rhees B; Bates M; Wolff AC; Gabrielson E; Harvey SC; Umbricht CB; Visvanathan K; Fackler MJ; Sukumar S
Clin Cancer Res; 2019 Nov; 25(21):6357-6367. PubMed ID: 31300453
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
16. Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.
Pirini F; Noazin S; Jahuira-Arias MH; Rodriguez-Torres S; Friess L; Michailidi C; Cok J; Combe J; Vargas G; Prado W; Soudry E; Pérez J; Yudin T; Mancinelli A; Unger H; Ili-Gangas C; Brebi-Mieville P; Berg DE; Hayashi M; Sidransky D; Gilman RH; Guerrero-Preston R
Oncotarget; 2017 Jun; 8(24):38501-38516. PubMed ID: 28418867
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor.
Kerachian MA; Javadmanesh A; Azghandi M; Mojtabanezhad Shariatpanahi A; Yassi M; Shams Davodly E; Talebi A; Khadangi F; Soltani G; Hayatbakhsh A; Ghaffarzadegan K
Sci Rep; 2020 Feb; 10(1):2813. PubMed ID: 32071364
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.
Yang JD; Ghoz H; Aboelsoud MM; Taylor WR; Yab TC; Berger CK; Cao X; Foote PH; Giama NH; Barr Fritcher EG; Mahoney DW; Moser CD; Smyrk TC; Kipp BR; Gores GJ; Roberts LR; Kisiel JB
Hepatol Commun; 2021 Aug; 5(8):1448-1459. PubMed ID: 34430788
[TBL] [Abstract][Full Text] [Related]
20. Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.
Maeda M; Yamashita S; Shimazu T; Iida N; Takeshima H; Nakajima T; Oda I; Nanjo S; Kusano C; Mori A; Moro H; Yamada H; Tsugane S; Sugiyama T; Sakai Y; Ushijima T
Gastric Cancer; 2018 Sep; 21(5):745-755. PubMed ID: 29427040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
